First-line ribociclib plus endocrine therapy outperforms combination chemotherapy Presented ByDr Yen-Shen Lu, National Taiwan University Hospital, Taiwan TrialPhase 2, RIGHT Choice ConferenceSABCS 2022 1 February, 2023 18:07